[The treatment of silicosis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D009921:Metaproterenol / Q000627:therapeutic use; D011205:Povidone / Q000627:therapeutic use*; D012118:Resorcinols / Q000627:therapeutic use; D012829:Silicosis / Q000188:drug therapy*; D012830:Silicotuberculosis / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D000995:Antitubercular Agents; D004071:Digitalis Glycosides; D005938:Glucocorticoids; D012118:Resorcinols; D013449:Sulfonamides; D009921:Metaproterenol; D013806:Theophylline; D011205:Povidone
Die Behandlung der Silikose.